On Friday, however, Novo Nordisk announced top-line results in yet another trial. While the results don't initially sound as ...
The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.
A new weight loss drug from Novo Nordisk helped patients lose a large amount of weight, providing a boost for Novo in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback